Spain moves to extend pre-implantation genetic screening:
This article was originally published in Clinica
The Spanish government is seeking to extend pre-implantation genetic screening to include tissue-typing for therapeutic purposes, Clinica understands. The health ministry's plans echo the UK's recent approval of the technique by the Human Fertilisation and Embryology Authority (see Clinica No 1118, p 6), but the approval of the technique in Spain will require legislative reforms. According to daily El Pais, the government expects these to be passed by the end of 2004. The use of the technique is being backed by the national commission for human assisted reproduction (CNRHA).
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.